Kate Yandell is a Philadelphia-based freelance writer with a love for genomics and neuroscience. She writes for Spectrum‘s Toolbox section.
Kate Yandell
Contributing Writer
Spectrum
From this contributor
With new part, CRISPR can cut RNA in living cells
A new version of the gene-editing tool CRISPR can target and cut RNA, offering a way to tinker with the expression of autism genes.
With new part, CRISPR can cut RNA in living cells
Sequencing approach bares large variety of brain cell types
Analyzing gene expression in a vision center of the mouse brain has revealed 49 different classes of cells.
Sequencing approach bares large variety of brain cell types
Precise program traces firing patterns in neural networks
By tracking calcium’s movement, a new algorithm simultaneously delineates individual neurons’ shapes as well as their firing patterns.
Precise program traces firing patterns in neural networks
Simple steps let star-shaped brain cells thrive in culture
A new method allows researchers to culture cells known as astrocytes from human brains.
Simple steps let star-shaped brain cells thrive in culture
Method marks variants among repeated DNA segments
A new tool trawls sequencing data to reveal single-letter DNA swaps within large duplications.
Method marks variants among repeated DNA segments
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.